Kiniksa Pharmaceuticals International (KNSA) Cost of Revenue (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) recorded Cost of Revenue of $23.57 million in Q2 2026, up 26.7% from $18.6 million a year earlier and up 13.3% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Cost of Revenue (2021 - 2026) Analysis & Trends
On a TTM basis, Kiniksa Pharmaceuticals International's Cost of Revenue came in at $85.57 million as of Jun 30, 2026, up 14.9% year-over-year; for FY2025, it was $77.67 million, up 27.5% from FY2024.
- Annual Cost of Revenue has increased for four straight years, with a four-year compound annual growth rate of 70.9% (FY2021 to FY2025).
- Across earlier years, Cost of Revenue came in at $60.91 million in FY2024 (+82.3%), $33.41 million in FY2023 (+45.9%), $22.9 million in FY2022 (+151.6%) and $9.1 million in FY2021.
- The Q2 2026 figure is the highest quarterly Cost of Revenue in data going back to Q2 2021.
- On a year-over-year basis, Cost of Revenue has increased for 17 consecutive quarters, with growth averaging 48.6% over the last eight quarters.
- The year-over-year growth in Cost of Revenue has ranged between 0.7% (Q3 2025) and 150.7% (Q3 2022) over the last five years.
- Per Business Quant, the preceding three quarters came in at $20.8 million (Q1 2026), $20.95 million (Q4 2025) and $20.26 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.82 Bn | 10.56 Bn | 220.03 Mn | 23.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.57 Mn |
| Mar 31, 2026 | 20.80 Mn |
| Dec 31, 2025 | 20.95 Mn |
| Sep 30, 2025 | 20.26 Mn |
| Jun 30, 2025 | 18.60 Mn |
| Mar 31, 2025 | 17.87 Mn |
| Dec 31, 2024 | 17.90 Mn |
| Sep 30, 2024 | 20.11 Mn |
| Jun 30, 2024 | 12.32 Mn |
| Mar 31, 2024 | 10.58 Mn |
| Dec 31, 2023 | 9.58 Mn |
| Sep 30, 2023 | 9.09 Mn |
| Jun 30, 2023 | 7.70 Mn |
| Mar 31, 2023 | 7.04 Mn |
| Dec 31, 2022 | 6.71 Mn |
| Sep 30, 2022 | 6.94 Mn |
| Jun 30, 2022 | 5.03 Mn |
| Mar 31, 2022 | 4.22 Mn |
| Dec 31, 2021 | 3.87 Mn |
| Sep 30, 2021 | 2.77 Mn |
API Access
Kiniksa Pharmaceuticals International Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();